Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. D‘Quino, A. Morris, J. Nash, B. Prathibha (Ashford, United Kingdom). T spot TB reactivity – ²to treat or not to treat². Eur Respir J 2009; 34: Suppl. 53, 2571

Member's Comments

No comment yet.

Related content which might interest you: LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Evaluation of difficult asthma – a single centre experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 Ways to shorten the lung clearance index measurement ΙΙ – How long to wash? Source: Annual Congress 2012 - New developments in paediatric respiratory physiology Year: 2012 Miliary tuberculosis during treatment with anti TNF alpha – A report of three cases Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 T spot TB – Changing trends and resource implications for trusts Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Freeflowmetry – The new method of evaluation of the respiratory function phenotype Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention Source: Annual Congress 2011 - Medical education Year: 2011 Tuberculosis – is there anything different over a decade? Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 PCD – As serious as CF in every day lung clinic? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011